I agree that this site is using cookies. You can find further informations here.
X
Gauler, T.
90  results:
Search for persons X
?
1

Prospects for online adaptive radiation therapy (ART) for h..:

Guberina, Maja ; Guberina, Nika ; Hoffmann, C....
Radiation Oncology.  19 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

HIGH RATE OF METABOLIC COMPLETE RESPONSE AFTER LOW DOSE RAD..:

Herfarth, K. ; Scholz, C. W. ; Hübel, K....
Hematological Oncology.  41 (2023)  S2 - p. 218-220 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Respiration-controlled radiotherapy in lung cancer: Systema..:

Guberina, M. ; Santiago, A. ; Pöttgen, C....
Clinical and Translational Radiation Oncology.  40 (2023)  - p. 100628 , 2023
Link: https://doi.org/10.1016/..
 
?
4

EP04.02-007 First Comprehensive Lung Cancer Long-Term Survi..:

Nadjm, S. ; Exner, J.-P.H. ; Hepp De Los Rios, R....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S263 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Systemic therapy in metastatic renal cell carcinoma (mRCC):..:

Grünwald, V. ; Bergmann, L. ; Brehmer, B....
World Journal of Urology.  40 (2022)  10 - p. 2381-2386 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Dose-escalated radiotherapy with PET/CT based treatment pla..:

Pöttgen, C. ; Gkika, E. ; Stahl, M....
Radiation Oncology.  16 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
7

PCN13 HANNA – REAL-WORLD EVIDENCE FROM A GERMAN, PROSPECTIV..:

von der Heyde, E. ; Welslau, M. ; Gauler, T....
Value in Health.  22 (2019)  - p. S437 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Prognostic Value of Metabolic Tumor Volume after Induction ..:

Guberina, M. ; Stuschke, M. ; Eberhardt, W....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. S146-S147 , 2019
Link: https://doi.org/10.1016/..
 
?
9

PCN508 A COMPARISON OF PATIENT CHARACTERISTICS TREATED WITH..:

von der Heyde, E. ; Welslau, M. ; Gauler, T....
Value in Health.  22 (2019)  - p. S536 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Cetuximab, fluorouracil and cisplatin with or without docet..:

Klinghammer, K. ; Gauler, T. ; Dietz, A....
European Journal of Cancer.  122 (2019)  - p. 53-60 , 2019
Link: https://doi.org/10.1016/..
 
?
11

OC-0493: Pretreatment metabolic volume in PET: Prognostic i..:

Guberina, M. ; Eberhardt, W.E.E. ; Stuschke, M....
Radiotherapy and Oncology.  127 (2018)  - p. S253-S254 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Biomarkers predict enhanced clinical outcomes with afatinib..:

Cohen, E.E.W. ; Licitra, L.F. ; Burtness, B....
Annals of Oncology.  28 (2017)  10 - p. 2526-2532 , 2017
Link: https://doi.org/10.1093/..
 
?
13

Population Modeling Integrating Pharmacokinetics, Pharmacod..:

Diekstra, MH ; Fritsch, A ; Kanefendt, F...
CPT: Pharmacometrics & Systems Pharmacology.  6 (2017)  9 - p. 604-613 , 2017
Link: https://doi.org/10.1002/..
 
?
14

Afatinib versus methotrexate in older patients with second-..:

Clement, P.M. ; Gauler, T. ; Machiels, J.P....
Annals of Oncology.  27 (2016)  8 - p. 1585-1593 , 2016
Link: https://doi.org/10.1093/..
 
?
15

Tumor Biomarker Association With Clinical Outcomes in Recur..:

Cohen, E. ; Licitra, L. ; Burtness, B....
International Journal of Radiation Oncology*Biology*Physics.  94 (2016)  4 - p. 868-869 , 2016
Link: https://doi.org/10.1016/..
 
1-15